rosomidnar liposomal (PNT2258) / GSK 
Welcome,         Profile    Billing    Logout  
 3 Diseases   1 Trial   1 Trial   28 News 
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Trial completion:  PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) (clinicaltrials.gov) -  Apr 22, 2020   
    P2,  N=45, Completed, 
    Despite demonstration of single-agent activity, ORR was lower than acceptable for further new therapy development. Active, not recruiting --> Completed
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Trial primary completion date:  PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) (clinicaltrials.gov) -  Mar 15, 2017   
    P2,  N=61, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Jul 2018 --> Sep 2016
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Trial primary completion date:  PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) (clinicaltrials.gov) -  Feb 27, 2017   
    P2,  N=61, Active, not recruiting, 
    Trial primary completion date: Jul 2018 --> Sep 2016 Trial primary completion date: Jan 2017 --> Jul 2018
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Trial completion, Trial primary completion date, IO biomarker:  Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (clinicaltrials.gov) -  Oct 21, 2016   
    P2,  N=13, Completed, 
    Trial primary completion date: Jan 2017 --> Jul 2018 Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Aug 2016
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Enrollment change, Trial termination, Trial primary completion date:  PNT2258 for Treatment of Patients With Richter's Transformation (Brighton) (clinicaltrials.gov) -  Jul 1, 2016   
    P2,  N=5, Terminated, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Aug 2016 N=49 --> 5 | Active, not recruiting --> Terminated | Trial primary completion date: Apr 2018 --> Jun 2016
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Trial primary completion date:  PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) (clinicaltrials.gov) -  Jun 23, 2016   
    P2,  N=61, Active, not recruiting, 
    N=49 --> 5 | Active, not recruiting --> Terminated | Trial primary completion date: Apr 2018 --> Jun 2016 Trial primary completion date: Oct 2016 --> Jan 2017
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Enrollment closed:  PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) (clinicaltrials.gov) -  Jun 21, 2016   
    P2,  N=61, Active, not recruiting, 
    Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Trial primary completion date:  PNT2258 for Treatment of Patients With Richter's Transformation (Brighton) (clinicaltrials.gov) -  Mar 11, 2016   
    P2,  N=49, Recruiting, 
    Trial primary completion date: Dec 2016 --> Dec 2017 Trial primary completion date: Oct 2017 --> Apr 2018
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Trial primary completion date, IO biomarker:  Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (clinicaltrials.gov) -  Jan 22, 2016   
    P2,  N=13, Active, not recruiting, 
    Trial primary completion date: Oct 2017 --> Apr 2018 Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Trial primary completion date, IO biomarker:  Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (clinicaltrials.gov) -  Mar 5, 2015   
    P2,  N=13, Active, not recruiting, 
    Trial primary completion date: Jul 2017 --> Oct 2017 Trial primary completion date: Dec 2014 --> Dec 2015
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Enrollment open:  PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) (clinicaltrials.gov) -  Dec 24, 2014   
    P2,  N=61, Recruiting, 
    Trial primary completion date: Dec 2014 --> Dec 2015 Not yet recruiting --> Recruiting
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Trial initiation date, Trial primary completion date:  PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine) (clinicaltrials.gov) -  Nov 19, 2014   
    P2,  N=62, Not yet recruiting, 
    Not yet recruiting --> Recruiting Initiation date: Oct 2014 --> Jan 2015 | Trial primary completion date: Apr 2016 --> Aug 2016
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Enrollment closed, IO biomarker:  Study of PNT2258 for Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma (clinicaltrials.gov) -  Oct 28, 2014   
    P2,  N=13, Active, not recruiting, 
    Initiation date: Oct 2014 --> Jan 2015 | Trial primary completion date: Apr 2016 --> Aug 2016 Recruiting --> Active, not recruiting
  • ||||||||||  rosomidnar liposomal (PNT2258) / GSK
    Trial completion, Metastases:  A Study of PNT2258 in Patients With Advanced Solid Tumors (clinicaltrials.gov) -  Nov 19, 2012   
    P1,  N=22, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed